These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33458928)

  • 41. Polyphenol- and Caffeine-Rich Postfermented Pu-erh Tea Improves Diet-Induced Metabolic Syndrome by Remodeling Intestinal Homeostasis in Mice.
    Gao X; Xie Q; Kong P; Liu L; Sun S; Xiong B; Huang B; Yan L; Sheng J; Xiang H
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29061705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.
    Larrosa M; González-Sarrías A; Yáñez-Gascón MJ; Selma MV; Azorín-Ortuño M; Toti S; Tomás-Barberán F; Dolara P; Espín JC
    J Nutr Biochem; 2010 Aug; 21(8):717-25. PubMed ID: 19616930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lythrum salicaria L. herb and gut microbiota of healthy post-weaning piglets. Focus on prebiotic properties and formation of postbiotic metabolites in ex vivo cultures.
    Dadi TH; Vahjen W; Zentek J; Melzig MF; Granica S; Piwowarski JP
    J Ethnopharmacol; 2020 Oct; 261():113073. PubMed ID: 32673710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Marine polysaccharides attenuate metabolic syndrome by fermentation products and altering gut microbiota: An overview.
    Wang X; Wang X; Jiang H; Cai C; Li G; Hao J; Yu G
    Carbohydr Polym; 2018 Sep; 195():601-612. PubMed ID: 29805017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in gut microbiota composition and metabolic parameters after dietary intervention with barley beta glucans in patients with high risk for metabolic syndrome development.
    Velikonja A; Lipoglavšek L; Zorec M; Orel R; Avguštin G
    Anaerobe; 2019 Feb; 55():67-77. PubMed ID: 30396006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients.
    Guo Y; Luo S; Ye Y; Yin S; Fan J; Xia M
    J Clin Endocrinol Metab; 2021 Jan; 106(1):64-79. PubMed ID: 33017844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. There is No Distinctive Gut Microbiota Signature in the Metabolic Syndrome: Contribution of Cardiovascular Disease Risk Factors and Associated Medication.
    Cortés-Martín A; Iglesias-Aguirre CE; Meoro A; Selma MV; Espín JC
    Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32183480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients.
    Xie X; He Y; Li H; Yu D; Na L; Sun T; Zhang D; Shi X; Xia Y; Jiang T; Rong S; Yang S; Ma X; Xu G
    Nutrition; 2019 May; 61():132-142. PubMed ID: 30711862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gut microbiota: a promising target against cardiometabolic diseases.
    Warmbrunn MV; Herrema H; Aron-Wisnewsky J; Soeters MR; Van Raalte DH; Nieuwdorp M
    Expert Rev Endocrinol Metab; 2020 Jan; 15(1):13-27. PubMed ID: 32066294
    [No Abstract]   [Full Text] [Related]  

  • 50. The therapeutic effect and possible mechanisms of alginate oligosaccharide on metabolic syndrome by regulating gut microbiota.
    Wang J; Zhang Z; Dai T; Zhang Z; Zhang Q; Yao J; Wang L; He N; Li S
    Food Funct; 2024 Sep; 15(19):9632-9661. PubMed ID: 39239698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
    Lambert JE; Parnell JA; Eksteen B; Raman M; Bomhof MR; Rioux KP; Madsen KL; Reimer RA
    BMC Gastroenterol; 2015 Dec; 15():169. PubMed ID: 26635079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity.
    Nicolucci AC; Hume MP; Martínez I; Mayengbam S; Walter J; Reimer RA
    Gastroenterology; 2017 Sep; 153(3):711-722. PubMed ID: 28596023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prebiotic supplementation over a cold season and during antibiotic treatment specifically modulates the gut microbiota composition of 3-6 year-old children.
    Soldi S; Vasileiadis S; Lohner S; Uggeri F; Puglisi E; Molinari P; Donner E; Sieland C; Decsi T; Sailer M; Theis S
    Benef Microbes; 2019 Apr; 10(3):253-263. PubMed ID: 30776899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of diet and intestinal microbiota in the development of metabolic syndrome.
    Santos-Marcos JA; Perez-Jimenez F; Camargo A
    J Nutr Biochem; 2019 Aug; 70():1-27. PubMed ID: 31082615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bletilla striata oligosaccharides improve metabolic syndrome through modulation of gut microbiota and intestinal metabolites in high fat diet-fed mice.
    Hu B; Ye C; Leung EL; Zhu L; Hu H; Zhang Z; Zheng J; Liu H
    Pharmacol Res; 2020 Sep; 159():104942. PubMed ID: 32504835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut Microbiota Composition is Associated with Responses to Peanut Intervention in Multiple Parameters Among Adults with Metabolic Syndrome Risk.
    Wang S; Zhang L; Wang D; Huang M; Zhao J; Malik V; Liu X; Sun L; Lin X; Chen Y
    Mol Nutr Food Res; 2021 Sep; 65(18):e2001051. PubMed ID: 34327851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut Microbiota Associations with Metabolic Health and Obesity Status in Older Adults.
    Zhong X; Harrington JM; Millar SR; Perry IJ; O'Toole PW; Phillips CM
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32784721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury.
    Yang S; Hu T; Liu H; Lv YL; Zhang W; Li H; Xuan L; Gong LL; Liu LH
    Biomed Pharmacother; 2021 Jun; 138():111441. PubMed ID: 33652261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults.
    Alfa MJ; Strang D; Tappia PS; Graham M; Van Domselaar G; Forbes JD; Laminman V; Olson N; DeGagne P; Bray D; Murray BL; Dufault B; Lix LM
    Clin Nutr; 2018 Jun; 37(3):797-807. PubMed ID: 28410921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.